DL
ELV icon

Delta Lloyd’s Elevance Health ELV Stock Holding History

Delta Lloyd’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$14.2M Sell
75,718
-29,986
-28% -$5.39M 0.4% 70
2017
Q1 		$17.5M Buy
105,704
+3,133
+3% +$498K 0.52% 49
2016
Q4 		$14.7M Buy
102,571
+7,963
+8% +$1.07M 0.46% 60
2016
Q3 		$11.9M Buy
94,608
+1,180
+1% +$152K 0.37% 83
2016
Q2 		$12.3M Sell
93,428
-725
-0.8% -$99.2K 0.41% 79
2016
Q1 		$13.1M Buy
94,153
+71,260
+311% +$9.52M 0.43% 72
2015
Q4 		$3.19M Sell
22,893
-67,948
-75% -$9.36M 0.11% 146
2015
Q3 		$12.7M Buy
90,841
+2,334
+3% +$351K 0.41% 70
2015
Q2 		$14.5M Buy
88,507
+8,270
+10% +$1.32M 0.45% 62
2015
Q1 		$12.4M Sell
80,237
-468
-0.6% -$66.6K 0.38% 54
2014
Q4 		$10.1M Buy
80,705
+2,856
+4% +$353K 0.3% 68
2014
Q3 		$27.9M Buy
77,849
+2,298
+3% +$264K 0.25% 62
2014
Q2 		$8.13M Buy
75,551
+673
+0.9% +$69.3K 0.26% 67
2014
Q1 		$7.45M Buy
74,878
+4,315
+6% +$390K 0.25% 67
2013
Q4 		$6.52M Sell
70,563
-5,697
-7% -$506K 0.23% 71
2013
Q3 		$6.38M Buy
76,260
+18,673
+32% +$1.6M 0.24% 91
2013
Q2 		$4.71M Buy
+57,587
New +$4.31M 0.18% 110

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Delta Lloyd's ELV Position: Q2 2017 in Review

Delta Lloyd reduced its Elevance Health (ELV) stake by 28% in Q2 2017, selling an estimated $5.39M and leaving 75,718 shares worth $14.2M. The position accounts for 0.4% of the portfolio, ranked #70.

Delta Lloyd first reported a position in ELV in Q2 2013 and has held it in 17 quarters since. The position peaked at $27.9M in Q3 2014. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Delta Lloyd held 75,718 shares of Elevance Health worth $14.2M as of Q2 2017.
  • Delta Lloyd sold 29,986 Elevance Health shares in Q2 2017, an estimated $5.39M.
  • Elevance Health made up 0.4% of Delta Lloyd's portfolio in Q2 2017, its #70 holding.
  • Delta Lloyd first reported a position in Elevance Health in Q2 2013 and has held it in 17 quarters since.
  • Delta Lloyd's Elevance Health position peaked at $27.9M in Q3 2014.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.